Rubina Baig
Family Medicine · Frankfort, ILNPI 1659809879
Payments from drug & device makers
Across 43 payments — averaging $20.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Hologic Sales And Service, LLC$126
- Boehringer Ingelheim$89
- Pharmacyclics LLC, An Abbvie Company$74
- AbbVie$54
- AstraZeneca$54
- Pfizer$50
- plus $430 from 18 others
What the payments were for
- Food & beverage$876100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Hologic Sales And Service, LLC | 1 | $126 |
| Boehringer Ingelheim | 5 | $89 |
| Pharmacyclics LLC, An Abbvie Company | 3 | $74 |
| AbbVie(2 entities) | 3 | $54 |
| AstraZeneca | 3 | $54 |
| Pfizer | 3 | $50 |
| Johnson & Johnson | 2 | $46 |
| Merck | 2 | $44 |
| Incyte Corporation | 3 | $41 |
| Novo Nordisk | 2 | $35 |
| Lilly USA, LLC | 2 | $32 |
| Bayer | 2 | $23 |
| Sobi, Inc | 1 | $22 |
| Daiichi Sankyo Inc. | 1 | $21 |
| Amarin Pharma, Inc. | 1 | $20 |
| Rigel Pharmaceuticals, Inc. | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Abbott | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Hikma Pharmaceuticals USA | 1 | $12 |
| Eisai Inc. | 1 | $12 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Aptima$126
How this compares
$876 in reported general payments places this provider in the 70th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| FarxigaDapagliflozin Propanediol | 11 | $15,595 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 19 | $2,363 |
| Levothyroxine Sodium | 27 | $396 |
| Atorvastatin Calcium | 68 | $278 |
| Amlodipine Besylate | 43 | $235 |
| Gabapentin | 21 | $219 |
| Metoprolol Succinate | 17 | $216 |
| Losartan Potassium | 21 | $196 |
| Omeprazole | 26 | $173 |
| Pravastatin Sodium | 13 | $133 |
| Lisinopril | 31 | $124 |
| Metformin Hcl | 38 | $109 |
| Hydrochlorothiazide | 17 | $47 |
| Sertraline Hcl | 13 | $31 |
| Alendronate Sodium | 16 | $25 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AstraZenecaFarxiga | $54 | $15,59511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Frankfort
- Errin ManneyFrankfort$167K
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.